ActoGeniX raises EUR 13.5M

ActoGeniX (Ghent, Belgium) raised EUR 13.5 million ($17.4 million) in an extension of a series A round, bringing the total raised in the round to EUR 33.5 million. New investor Biovest and existing investors Gimv; Biotech Fund Flanders; Baekeland Fund; VIB; LSP; Aescap; and Ventech participated. ...